ROTH makes a market in shares of VBL Therapeutics and as such, buys and sells from customers on a principal basis. Shares of VBL Therapeutics may be subject to the Securities and Exchange Commission’s …
More Developer of Oncology Therapeutics to Have ‘Catalyst Rich’ 2020 Videos